Pacira Pharmaceuticals, Inc.
Clinical trials sponsored by Pacira Pharmaceuticals, Inc., explained in plain language.
A pharmaceutical company focused on non-opioid pain management therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a freezing device loosen stiff muscles? new trial begins Results expected Oct 2026 (estimated)
- One-Shot gene therapy could ease knee arthritis pain for years Results expected Nov 2026 (estimated)
- New shot aims to ease shoulder arthritis pain Results expected Dec 2026 (estimated) 🚀 Make-or-break
- New pain relief for tiny hearts: study tests EXPAREL in kids under 6 Results expected Jan 2027 (estimated)
-
One-Shot gene therapy could ease knee arthritis pain for years
Symptom relief Recruiting nowThis Phase 2 trial tests a single injection of a gene therapy called PCRX-201 in 135 adults aged 45–80 with painful knee osteoarthritis. Participants receive one of two doses or a placebo, then are monitored for safety and pain relief over 5 years. The goal is to see if the injec…
Phase 2 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
New pain relief for tiny hearts: study tests EXPAREL in kids under 6
Symptom relief Recruiting nowThis study is for children under 6 years old who need heart surgery. It tests a pain medicine called EXPAREL to see if it works well and is safe compared to a standard painkiller. The medicine is given near the surgery area to help with pain after the operation. About 48 children…
Phase 1 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
10,000 knee pain patients enrolled in massive treatment registry
Knowledge-focused Recruiting nowThis registry will follow 10,000 people receiving various pain treatments for knee osteoarthritis, such as injections, nerve blocks, or knee replacement. Researchers will track pain levels, function, sleep, and side effects over time. The goal is to learn which approaches work be…
Sponsor: Pacira Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC